March 2014 — Present
Biological analysis of autoimmune and inflammatory disorders to provide necessary background information for developing in silico based, customized simulations of clinical trials. Primary focuses currently reside in RA, Ps/PsA and Sepsis/Infection. Such models are used to accelerate scientific innovation and discovery, minimize costs and risk to market, and increase productivity. Current collaborations include academia and pharmaceutical companies. Additionally, heading up the re-marketing initiative to boost our website appeal to potential clients and other target audiences.